I believe Brilacidin had shown promise as an optical bacterial infection treatment some time ago. Think of all the people that have lost their sight due to these infections and the additional people that have lost their eyesight due to fungal infections since that time.
Makes one wonder why the optical world of medicine (to include patient groups looking for answers to eye loss issues) hasn't been pushing to further study B in this area for some years now? Something is wrong w/ the system for a possible savior for millions of people to save their eyesight has been sitting on the shelf for these many years.
It can't be left strictly to BP as their main interest is making money, not helping patients, which falls further down the list of priorities IMO.
Same goes for Kevetrin and the potential it showed for retinoblastoma cancer treatment in babies and very young children. Lots of pain, suffering, and eyesight loss when a possible very effective treatment may have been right around the corner. I am sure many parents of babies with retino.... would have risked their child being treated w/ Kevetrin to try and save their sight, especially with the outstanding safety profile K showed in clinical testing.
Just an opinion.
News 
Market Data 
Discover 
